Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial
作者： Stephen B. Hanauer , William J. Sandborn , Paul Rutgeerts , Richard N. Fedorak , Milan Lukas
DOI: 10.1053/J.GASTRO.2005.11.030
关键词: Gastroenterology 、 Adalimumab 、 Management of Crohn's disease 、 Crohn's disease 、 Placebo 、 Surgery 、 Clinical endpoint 、 Certolizumab pegol 、 Internal medicine 、 Crohn's Disease Activity Index 、 C-reactive protein 、 Medicine
摘要: Background & Aims: Tumor necrosis factor blockade has been shown to be an effective … Adalimumab is a human immunoglobulin G1 (IgG 1 ) monoclonal antibody targeting tumor …
gastrojournal.org
core.ac.uk
elsevier.com
rima.org 参考文章(33)
Bruce E. Sands, Frank H. Anderson, Charles N. Bernstein, William Y. Chey, Brian G. Feagan, Richard N. Fedorak, Michael A. Kamm, Joshua R. Korzenik, Bret A. Lashner, Jane E. Onken, Daniel Rachmilewitz, Paul Rutgeerts, Gary Wild, Douglas C. Wolf, Paul A. Marsters, Suzanne B. Travers, Marion A. Blank, Sander J. van Deventer, Infliximab Maintenance Therapy for Fistulizing Crohn's Disease New England Journal of Medicine. ,vol. 350, pp. 876- 885 ,(2004) , 10.1056/NEJMOA030815
C.P. Braegger, S. Nicholls, S.H. Murch, T.T. MacDonald, S. Stephens, Tumour necrosis factor alpha in stool as a marker of intestinal inflammation The Lancet. ,vol. 339, pp. 89- 91 ,(1992) , 10.1016/0140-6736(92)90999-J
S H Murch, V A Lamkin, M O Savage, J A Walker-Smith, T T MacDonald, Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. ,vol. 32, pp. 913- 917 ,(1991) , 10.1136/GUT.32.8.913
Edward C. Keystone, Arthur F. Kavanaugh, John T. Sharp, Hyman Tannenbaum, Ye Hua, Leah S. Teoh, Steven A. Fischkoff, Elliot K. Chartash, Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial Arthritis & Rheumatism. ,vol. 50, pp. 1400- 1411 ,(2004) , 10.1002/ART.20217
W J Sandborn, CDP571, a humanised monoclonal antibody to tumour necrosis factor , for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial Gut. ,vol. 53, pp. 1485- 1493 ,(2004) , 10.1136/GUT.2003.035253
Michael H. Weisman, Larry W. Moreland, Daniel E. Furst, Michael E. Weinblatt, Edward C. Keystone, Harold E. Paulus, Leah S. Teoh, Raja B. Velagapudi, Peter A. Noertersheuser, G.Richard Granneman, Steven A. Fischkoff, Elliot K. Chartash, Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study Clinical Therapeutics. ,vol. 25, pp. 1700- 1721 ,(2003) , 10.1016/S0149-2918(03)80164-9
Jan M.H Van den Brande, Henri Braat, Gijs R van den Brink, Henri H Versteeg, Christiaan A Bauer, Inge Hoedemaeker, Catherine van Montfrans, Daan W Hommes, Maikel P Peppelenbosch, Sander J.H van Deventer, Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease Gastroenterology. ,vol. 124, pp. 1774- 1785 ,(2003) , 10.1016/S0016-5085(03)00382-2
R Rau, S Simianer, PLCM van Riel, LBA van de Putte, K Krüger, M Schattenkirchner, CF Allaart, FC Breedveld, J Kempeni, K Beck, H Kupper, Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. Scandinavian Journal of Rheumatology. ,vol. 33, pp. 145- 153 ,(2004) , 10.1080/03009740410005467
Stephen B Hanauer, Carrie L Wagner, Mohan Bala, Lloyd Mayer, Suzanne Travers, Robert H Diamond, Allan Olson, Warren Bao, Paul Rutgeerts, Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease Clinical Gastroenterology and Hepatology. ,vol. 2, pp. 542- 553 ,(2004) , 10.1016/S1542-3565(04)00238-1
S J Van Deventer, Tumour necrosis factor and Crohn's disease. Gut. ,vol. 40, pp. 443- 448 ,(1997) , 10.1136/GUT.40.4.443